A federal judge says he will continue to pause the Trump administration's federal employee buyout offer until he issues a ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

FRENCH grocer Carrefour submitted a proposal for a take-private of its Brazilian subsidiary Atacadao. Read more at The ...

An interesting narrative is making rounds on Twitter (now X), and it all started when a certain Nathan shared a post ...

OpenAI CEO Sam Altman gave an unequivocal answer at a conference in Paris today when asked whether his company was for sale following a surprise $97.4 billion bid by an Elon Musk-led investor group.

As part of President Donald Trump's efforts to trim government spending, the Office of Personnel Management recently offered ...

Discover why Canadian Pacific Kansas City is a top investment choice, leveraging its monopoly position, cross-border reach, ...

OpenAI CEO Sam Altman has dismissed Elon Musk’s $97.4 billion buyout bid for the AI startup, calling it an attempt made “from ...

President Trump has empowered Elon Musk, the richest man in the world, to gut the federal bureaucracy. Here's 5 ways he's starting to carry it out.

British bookmaker Entain has today announced the sudden departure of CEO Gavin Isaacs after just five months in the role, ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Unifor criticized the move, which follows more than 6,000 layoffs in the last two years, as shortsighted and a “damaging stunt.” ...